REGENERON PHARMACEUTICALS, INC. Gain (Loss) on Investments
REGENERON PHARMACEUTICALS, INC. (REGN) reported Gain (Loss) on Investments of -$293.00 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-17.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2011-02-17
- REGENERON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2010-12-31 was -$51.00K.
- REGENERON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2010-09-30 was -$42.00K, a 175.00% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2009-12-31 was $0.00.
- REGENERON PHARMACEUTICALS, INC. gain (loss) on investments for the quarter ending 2009-09-30 was $56.00K.
- REGENERON PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2010 was -$293.00K, a 623.21% decline from fiscal 2009.
- REGENERON PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2009 was $56.00K.
- REGENERON PHARMACEUTICALS, INC. gain (loss) on investments for fiscal 2008 was -$1.31M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2010-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | -$93.00K derived: sum of 2 quarters · filed 2011-02-17 | -$293.00K 10-K · filed 2011-02-17 | |
| 2010-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$242.00K 10-Q · filed 2010-10-28 | ||
| 2010-06-30 | -$200.00K 10-Q · filed 2010-07-28 | |||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $56.00K derived: sum of 2 quarters · filed 2011-02-17 | $56.00K 10-K · filed 2011-02-17 | |
| 2009-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $56.00K 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $0.00 10-Q · filed 2010-07-28 | |||
| 2008-12-31 | -$1.31M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |